SecBot SecBot

KOD

Kodiak Sciences Inc.
Nasdaq· Biological Products, (No Diagnostic Substances)· Inc. DE· CIK 0001468748 Biotech & Drug Discovery
$100.73 −10.46 (−9.41%)
Nov 16 4:00 PM ET · prev $111.19
Market cap
$7.1B
Mid cap
Consensus
Buy
82% Buy or better · 11 analysts
Median target
$128.50
+28% · range $103.00–150.00
1 year
+408.0%
from $19.83 · Nov 17
30 days
+10.3%
from $91.35
52-week range
$19.22–111.19
−9% from high · low Nov 18
Avg volume 20D
852.5K
shares / day
Short interest
8.12M
≈12.9% of shares · −4.5%
Days to cover
9.3
at average volume
Insider net
+$73.4M
1 buyer · 1 seller · since Sep 28
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
13
analyzed by SecBot
SecBot read MIXED 8 reports · 90 days
Balance 3 bearish · 5 bullish oldest → newest, height = score
Avg score ·High conf. 5/8

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBULLISH

    1 insider bought $76.1M at an average $87.30. 1 insider sold $2.7M. Price is 15% above their cost.

  • InstitutionsBULLISH

    Q2 2026: 27 added (0 new), 15 trimmed or exited.

  • AnalystsBULLISH

    9 of 11 rate it Buy or better. Every target is above the price.

  • EstimatesFLAT

    Current-quarter EPS estimate −$0.996 → −$0.984 over 90 days. 2 up, 0 down in 30 days.

  • Short sellersSTEADY

    Short interest −4.5% to 8.12M shares. 9.3 days to cover, ≈12.9% of shares.

  • TrendUPTREND

    29% above its 50-day average. New closing high $111.19 on Nov 13.

  • SocialQUIET

    No Reddit mentions this week. Last mention Nov 9.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
PRICE T ROWE ASSOCIATES INC /MD/ADD3,248,611$126.6M
GOLDMAN SACHS GROUP INCADD2,316,014$90.2M
Artisan Partners Limited PartnershipADD968,037$37.7M
WELLINGTON MANAGEMENT GROUP LLPADD793,613$30.9M
VANGUARD PORTFOLIO MANAGEMENT LLCADD532,819$20.8M
BANK OF AMERICA CORP /DE/ADD383,709$14.9M
FMR LLCADD276,984$10.8M
RENAISSANCE TECHNOLOGIES LLCTRIM189,200$7.4M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

11 analysts
Buy 82% rate it Buy or better
Strong Buy2Buy7Hold2Sell0Strong Sell0
12-month targets · 6 analysts

Price is below the lowest target. Median implies +28%.Targets as of Nov 16, 2026.

Recent actions
DateFirmActionRating
Nov 13, 2026UBS
MAINTAIN
MAINTAINBuy
Oct 12, 2026HC Wainwright & Co.
MAINTAIN
MAINTAINBuy
Sep 28, 2026LifeSci Capital
MAINTAIN
MAINTAINOutperform
Sep 28, 2026UBS
MAINTAIN
MAINTAINBuy
Sep 28, 2026HC Wainwright & Co.
MAINTAIN
MAINTAINBuy
Sep 17, 2026HC Wainwright & Co.
REITERATE
REITERATEBuy

Insider ledger

Form 4
$76.1M
bought · 1 insider
$2.7M
sold · 1 insider
+15.4%
vs their $87.30 cost
DateInsiderTypeValue
Nov 5, 2026
BAKER BROS. ADVISORS LP
Director
Nov 5, 2026
BUY$8.1M
Nov 5, 2026
BAKER BROS. ADVISORS LP
Director
Nov 5, 2026
BUY$463.3K
Nov 4, 2026
BAKER BROS. ADVISORS LP
Director
Nov 4, 2026
BUY$861.2K
Nov 4, 2026
BAKER BROS. ADVISORS LP
Director
Nov 4, 2026
BUY$15.0M
Oct 23, 2026
Yang Taiyin
Director
Oct 23, 2026
EXERCISE$47.0K
Oct 21, 2026
BORGESON JOHN A.
Chief Financial Officer
Oct 21, 2026
EXERCISE$74.7K
Oct 21, 2026
BORGESON JOHN A.
Chief Financial Officer
Oct 21, 2026
SELL$746.4K
Oct 21, 2026
BORGESON JOHN A.
Chief Financial Officer
Oct 21, 2026
SELL$149.6K

Earnings setup

Estimates
−$0.98
EPS estimate, this quarter
+1%
estimate change, 90 days
2↑ 0↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.98-$1.05–-$0.93-0.0%$0.00
Next Q-$1.16-$1.16–-$1.16No data$0.00
Current FY-$4.03-$4.09–-$3.99-1.2%$0.00
Next FY🔒 Fresh data, subscribers only
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
3 drugs tracked · Drug pipeline →
Recent
Nov 12, 2026
Earnings
Kodiak Sciences Announces Recent Business Highlights and Third Quarter 2026 Financial Results
PALO ALTO, Calif., Nov. 12, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results…
Nov 12, 2026
Earnings result
KOD Q3 2026 Earnings: EPS $-1.05 (+2.1% vs est)
Nov 11, 2026
Press release
Kodiak Sciences to Present at Three Upcoming Investor Conferences
PALO ALTO, Calif., Nov. 11, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina-focused biotechnology company committed…
Sep 25, 2026
Company news
Kodiak Sciences to Present Topline Results on September 28, 2026 from DAYBREAK Pivotal Phase 3 Study of Zenkuda and KSI-501 in Patients with Wet Age-Related Macular Degeneration
Kodiak Sciences to Host Webcast on Monday, September 28 at 8:30 AM Eastern Time PALO ALTO, Calif., Sept. 25, 2026 /PRNewswire/ -- Kodiak Sciences…
Aug 19, 2026
Earnings date
KOD Q2 2026 Earnings Scheduled, 2026-08-19

Short side

FINRA· Oct 30, 2026
8,115,058
shares short
-4.5%
vs prior settlement
9.3
days to cover
≈12.9%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 16, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Nov 16, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Nov 12, 2026 SEC
Kodiak Sciences reported Q3 2026 results with a net loss of $66.2M ($1.05/share), wider than the $61.5M loss in Q3…
8-K · Impact 6/10
Nov 12, 2026 Earnings
Kodiak Sciences Announces Recent Business Highlights and Third Quarter 2026 Financial Results
PALO ALTO, Calif., Nov. 12, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported
Nov 5, 2026 Insider
BAKER BROS. ADVISORS LP bought 81,729 shares
Director @ $98.51 ($8.1M)
Nov 5, 2026 Insider
BAKER BROS. ADVISORS LP bought 4,703 shares
Director @ $98.51 ($463.3K)
Nov 4, 2026 Insider
BAKER BROS. ADVISORS LP bought 8,742 shares
Director @ $98.51 ($861.2K)
Jun 30, 2026 Inst.
PRICE T ROWE ASSOCIATES · ADD
3,248,611 shares ($126.6M)
Reddit
Recent posts
All social signals and their track records

SecBot reports

13 filings · 7 bullish · 3 bearish · 3 neutral
All KOD filing & press-release reports (13)